Please login to the form below

Incivek

This page shows the latest Incivek news and features for those working in and with pharma, biotech and healthcare.

Access to new hep C treatments put under the spotlight

It can also be used in patients with advanced liver disease and who have failed prior treatment with HCV protease inhibitors such as Merck &Co's Victrelis (boceprevir) and Vertex' Incivek

Latest news

FDA approves four new medicines across multiple areas

and Vertex' Incivek (telaprevir).
J&J starts to feel biosimilar competition bite

toll on J&J's Olysio (simeprevir) and Incivek (telaprevir) products.
Top biotech firms saw sales jump in 2014

Dion added: “This drop was largely attributable to sliding sales of Incivek (telaprevir), Vertex's hepatitis C virus protease inhibitor, which fell by $442.3m compared with 2013, primarily as a
The end of hepatitis C?

The launch a few years ago of first-generation protease inhibitors to the pharmaco-therapeutic arsenal - Vertex' Incivek (telaprevir) and Merck &Co's Victrelis (boceprevir) - drastically improved success rates in some
BMS can ride on Sovaldi's success as Daklinza cleared in EU

patients with advanced liver disease and who have failed prior treatment with HCV protease inhibitors such as Merck &Co's Victrelis (boceprevir) and Vertex' Incivek (telaprevir).

More from news
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest Intelligence

Vertex: a vision of treating all CF patients worldwide draws closer

a decade of trial and error, the company had a huge breakthrough drug on its hands: hepatitis C treatment Incivek. ... Launched in 2011, Incivek enjoyed the most successful launch in pharma history, earning $1.6bn in sales during its first 12 months on.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Warehousing of HCV patients reaches new high

New drugs from Vertex (Incivek) and Merck (Victrelis) have been welcomed because they are more effective, but they still need to be given with Interferon.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Director – Healthcare PR: Salary TBC

Senior Medical Writer: Competitive salary and benefits

Account Director, Medical Education: Salary TBC

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Editor – Medical Education Agency – Bucks: Salary TBC

Senior Medical Writer: Salary TBC

PR Associate Director – Consumer Health & Beauty: Salary TBC

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Subscribe to our email news alerts

PMHub

Add my company

Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...